These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3578929)

  • 1. Problems with generic theophylline and indiscriminate brand switching.
    Klein GL
    Ann Allergy; 1987 May; 58(5):350-2. PubMed ID: 3578929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and taste acceptance of an alcohol-free oxtriphylline solution.
    Kadlec GJ; Jarboe CH; Sublett J; Pollard S; Ha L; Ellenberg D; Karibo JM; Simon T; Katsampes C
    Ann Allergy; 1980 Oct; 45(4):224-7. PubMed ID: 7425393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between pharmacodynamics and pharmacokinetics in asthmatic children receiving a sustained-release formulation of theophylline.
    Schaefers M; Richter O; Reinhardt D; Becker B
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):406-15. PubMed ID: 6490223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacokinetic approach to the use of theophylline in status asthmaticus.
    Cohen RM
    Ann Allergy; 1985 Jan; 54(1):1-11. PubMed ID: 3881058
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic and toxic theophylline levels in asthma attacks--is there a need for additional theophylline?].
    Zeidman A; Gardyn J; Fradin Z; Fink G; Mittelman M
    Harefuah; 1997 Jul; 133(1-2):3-5, 80. PubMed ID: 9332046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of pharmacokinetic profile in evaluating patients with repeatedly low theophylline concentrations.
    Georgitis JW; Szefler SJ; Baswell B; Shen DD
    Ann Allergy; 1984 Sep; 53(3):231-5. PubMed ID: 6476482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of asthma with theophylline preparations].
    Slapke J; Hummel S; Wilke A; Wenz W; Meister W; Förster R; Wiesner B; Nussbücker B
    Z Erkr Atmungsorgane; 1988; 170(1):32-48. PubMed ID: 3291416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Theophylline in childhood asthma. Pharmacokinetic and clinical study (author's transl)].
    Bellon G; Plasse JC; Satta S; Barbier Y; Gilly R
    Rev Fr Mal Respir; 1981; 9(2):113-21. PubMed ID: 7255850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Problems with generic theophylline and indiscriminate brand switching.
    Barreuther A
    Ann Allergy; 1988 Mar; 60(3):275-6. PubMed ID: 3348509
    [No Abstract]   [Full Text] [Related]  

  • 10. Theophylline: constant-rate infusion predictions.
    Mesquita CA; Sahebjami H; Imhoff T; Thomas JP; Myre SA
    Ther Drug Monit; 1984; 6(2):157-63. PubMed ID: 6740734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of theophylline in infantile bronchial asthma. Clinical findings].
    Martínez Sampere JJ; Girón F; Olea N; Loscertales M; Ruiz Estremera A; Puentes C; Pedraza V
    An Esp Pediatr; 1982 Jul; 17(1):6-17. PubMed ID: 6182822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of 11 methods for predicting theophylline dose.
    Rodvold KA; Paloucek FP; Zell M
    Clin Pharm; 1986 May; 5(5):403-8. PubMed ID: 3720210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theophylline for chronic asthma: rationale for treatment, product selection, and dosage schedule.
    Weinberger M; Hendeles L
    Pediatr Pharmacol (New York); 1983; 3(3-4):273-85. PubMed ID: 6429620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of determining the serum theophylline level in the controlled treatment of bronchial asthma].
    Chrostowski K; Ciszek J
    Pneumonol Pol; 1983 Jan; 51(1):55-62. PubMed ID: 6348711
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma.
    Tinkelman DG; Miller E; Janky DG; Decouto J; Edelman L
    Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a pharmacokinetic method for establishing doses of aminophylline to treat acute bronchospasm.
    Pancorbo S; Davies S; Raymond JL
    Am J Hosp Pharm; 1981 Jun; 38(6):851-6. PubMed ID: 7246557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-acting versus a long-acting preparation of theophylline ('Xantivent') in the treatment of reversible bronchospasm.
    Andrasch R; Schmitz-Schumann M
    Pharmatherapeutica; 1984; 3(10):668-77. PubMed ID: 6463066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The theophylline test. Indications for the effective daily dosage (author's transl)].
    Blaive B; Bugnas B; Lapalus P; Lemoigne F
    Rev Fr Mal Respir; 1982; 10(3):205-12. PubMed ID: 7111830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal administration of theophylline in aqueous solution.
    Pedersen S; Sommer B
    Acta Paediatr Scand; 1981 Mar; 70(2):243-6. PubMed ID: 7234406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of bronchospastic attack and the asthmatic state].
    Komarov FI; Daniliak IG
    Sov Med; 1977 Sep; (9):117-22. PubMed ID: 929283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.